USD/CHF
Dollar hits two-month high as Swiss franc, yen weaken on hawkish Fed outlook
The dollar rose 0.14% to 101.27 for a fourth straight daily advance, pressing the franc to its lowest level since May 2025, as Fed officials opened the door to further rate increases.
Swiss franc rallies as USD/CHF drops below 0.8200, SNB warns of FX intervention
The Swiss franc strengthened against the dollar, with the pair slipping below 0.8200, while the SNB signaled readiness to intervene amid heightened Middle East risk.
Eurozone yields near decade highs amid Brent crude surge and ECB-Fed watch
U.S. Treasury yields hover just below 5% as Brent crude climbs 3% ahead of ECB and Fed rate decisions.
SMI opens higher with Galderma, Sandoz debuts amid KI chip demand
Swiss equity markets expected to start the week on a positive note, with the SMI index poised for gains as pharmaceutical firms Galderma and Sandoz make their debut. Meanwhile, oil prices retreated despite escalating tensions in the Middle East.
Swiss Market Open Under Pressure as US Futures, Oil Rise and FX Shifts Dominate
Asian markets and Swiss equities face headwinds from rising Brent crude, US futures declines and expectations of Fed rate hikes.
Swiss SMI up 0.2% pre-market as 18 of 20 components rise
Alcon shares decline sharply amid pre-market trading; Brent crude stays above $100 amid geopolitical tensions
Swiss Market Index rises; Roche downgraded, Rieter hit by UBS rating cut
Swiss equities mixed as SMI gains, but Roche and Rieter face downgrades; oil prices dip amid geopolitical uncertainty and Fed rate hike expectations.
Why Is the Swiss Franc So Strong — and What Does It Mean for Switzerland?
The Swiss franc has a reputation that extends far beyond the borders of Switzerland.
Swiss SMI slides over 1%, LVMH hits six‑year low, ABB leads gains
The Swiss market index fell to 14,221 as LVMH reached its lowest level since 2018, while ABB posted the biggest rise; USD/CHF slipped to 80.89 Rappen and US exchanges stayed closed for a holiday.
Swiss equities slip as US markets close, Novartis drags index lower; USD/CHF falls
The SMI fell 1.2% to 14,221 points after Novartis lost 3.3% on a failed drug trial, while the franc edged higher to 80.89 per dollar and USD/JPY slipped to 154.07 yen.
Swiss market slides as Novartis falls on failed drug trial, dollar weakens against franc
The SMI dropped over 1% to 14,221 points, led by a 3% slide in Novartis after negative Pelacarsen news, while the U.S. dollar fell to 80.89 rappen.
US stocks rise on Fed rate pause hopes; Swiss franc strengthens
Wall Street advances as investors bet on a September Fed pause, while the Swiss franc gains after higher-than-expected Swiss inflation. SMI mixed as Nestlé weighs on index.
US equities mixed; SMI edges lower as oil hits four-week high
Futures on the Dow slipped 0.13% while Nasdaq futures rose 0.1% ahead of U.S. open. Brent crude surged 2.6% to $94.04/bbl, nearing $100/bbl. Swiss Re and Logitech led SMI laggards.
USD/CHF bears regain control as Swiss franc draws haven flows
U.S. Treasury’s expanded long-end buybacks and shifting correlations fuel safe-haven demand for the franc, pushing USD/CHF below key support. Technicals and fundamentals suggest further downside if resistance holds.
U.S. Treasury doubles long-dated bond buybacks after yield surge
Long-dated U.S. Treasury yields fell 10 bps after the government doubled planned bond buybacks. Stocks rose, gold and bitcoin gained, while the dollar weakened sharply against the Swiss franc.
US stocks rise as Moderna surges; US net interest costs hit record high
Moderna’s 118% rally lifts biotech and Swiss pharma; Dow, S&P 500 and Nasdaq 100 advance. US net interest payments climb to 3.3% of GDP, highest on record.
Four major FX pairs align, inflation data eyed
Rare simultaneous strength in EUR/USD, GBP/USD, USD/JPY and USD/CHF shifts focus to upcoming inflation releases for policy cues.